Hidden Consequences of Interim Analyses & Adaptive Trial Options

Frontiers OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany

Statistical Considerations for Clinical Trials During COVID-19: Interim Analysis with Adaptive Estimands Based

INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

PDF) Interim analysis: A rational approach of decision making in clinical trial

Hidden Consequences of Interim Analyses & Adaptive Trial Options - Quantics Biostatistics

JCM, Free Full-Text

Guidance on interim analysis methods in clinical trials, Journal of Clinical and Translational Science

Application of Bayesian approaches in drug development: starting a virtuous cycle

HOPE-3 trial of DMD therapy CAP-1002 to continue as planned

Quantics Biostatistics Clinical Biostatistics Service